Photocure ASA(PHCUF)
USD --+0.00%
Reward58Moderate
Risk32Moderate
📊75%Data
Thin -0% profit margin
PHCUF
+0.0 · +0.00%
USD · PINK
Photocure ASA | Healthcare
Balanced
Market Cap:196.83M
ℹ️
Reward Rating
58
Moderate
Top 50% (model universe)
75% data coverage
ℹ️
Risk Rating
32
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on PHCUF to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Photocure ASA?

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.

PHCUF · Verdict

Solid reward · moderate risk

PHCUF scores well on volatility and balance sheet with no major weaknesses flagged in the model.

Based on 88% data coverage

PHCUF · Verdict

What’s working & what to watch

Strengths 2

  • Volatility80/100

    Top decile vs peers

  • Balance sheet79/100

    Interest covered 3.3×

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Photocure ASA?

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 196.83M, and a P/E ratio of 700.0x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Adequate profitability with some margin variability in recent periods.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: Moderate (58)

The scoring profile indicates moderate reward potential, with growth and profitability as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap196.83M
P/E Ratio700
Dividend YieldN/A
52 Week High7
52 Week Low4.32
Last AnnualDecember
IPO DateN/A
IncorporatedUSA
Shares Outstanding27M
No. of Employees102
IndustryDrug Manufacturers - Specialty & Generic
ExchangePINK
Beta0.374
CurrencyUSD